𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A comparative study of transitional cell tumors of the bladder and upper urinary tract

✍ Scribed by Ebbe Kvist; Anne Falensteen Lauritzen; Jesper Bredesen; Michael Luke; Knud-Erik Sjølin

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
326 KB
Volume
61
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrent urothelial tumors following su
Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract
✍ David W. Strong; Harper D. Pearse 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 1 views

A retrospective analysis of 74 cases of transitional cell carcinoma of the renal pelvis and ureter treated at this institution over the past 30 years is presented. When nephrectomy alone or incomplete nephroureterectomy was performed, subsequent transitional cell carcinoma developed in 30% of the ur

A phase II study of mitoguazone and vinb
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract
✍ John T. Barrett; Bruno Orofiamma; Janardan D. Khandekar; Paul P. Carbone; Robert 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

This is a comparative study to evaluate response rate to mitoguazone (MGBG) and vinblastine (VLB) in 52 evaluable patients with advanced transitional cell carcinoma of the urinary tract. Of 38 patients with measurable disease, two of 18 (11%) on MGBG had partial remission (95% confidence interval: 0

A study of cyclophosphamide, adriamycin,
A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract
✍ Dennis L. Citrin; Tom F. Hogan; Tom E. Davis 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Twenty patients with locally advanced and/or metastatic transitional cell cancer of the urinary tract were treated with cyclophosphamide 500 mg/m2, Adriamycin (doxorubicin) 40 mg/m2 and cis-platinum (CDDP) 40 mg/m2 given every three weeks for 2 cycles, alternating with methotrexate 40 mg/m2 weekly f